openPR Logo
Press release

Autism-Pipeline Review H1 2018

08-07-2018 09:34 AM CET | Health & Medicine

Press release from: ReportsWeb

Reportsweb

Reportsweb

ReportsWeb.com has announced the addition of the “Global Autism Market Size Status and Forecast 2018”, The report classifies the global Autism Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review, H1 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape.Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child's sex, family history, fragile X syndrome, Tourette syndrome and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives.

Get Sample Copy at http://www.reportsweb.com/inquiry&RW00011444203/sample

Pharmaceutical and Healthcare latest pipeline guide Autism-Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Autism (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Autism (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Autism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 1, 6, 3, 1, 25, 4 and 2 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 2 and 1 molecules, respectively.

Autism (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The Key Players mentioned in our report:
4D Pharma PLC, Addex Therapeutics Ltd, AgeneBio Inc, Anima Biotech Ltd, APeT Holding BV, Bantam Pharmaceutical LLC, BioHealthonomics Inc, BrainStorm Cell Therapeutics Inc, Confluence Pharmaceuticals LLC, Coronis NeuroSciences Ltd, Curemark LLC, DRI Biosciences Corp, Evgen Pharma Plc, GW Pharmaceuticals Plc, Heptares Therapeutics Ltd, Immuron Ltd, Intra-Cellular Therapies Inc, Leading BioSciences Inc, MedDay SA, Omeros Corp, OptiNose US Inc, Otsuka Holdings Co Ltd, Ovensa Inc, RespireRx Pharmaceuticals Inc, SkySea Pharmaceutical Inc,Sumitomo Dainippon Pharma Co Ltd

Scope

-The pipeline guide provides a snapshot of the global therapeutic landscape of Autism (Central Nervous System).
-The pipeline guide reviews pipeline therapeutics for Autism (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
-The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
-The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
-The pipeline guide reviews key companies involved in Autism (Central Nervous System) therapeutics and enlists all their major and minor projects.
-The pipeline guide evaluates Autism (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
-The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
-The pipeline guide reviews latest news related to pipeline therapeutics for Autism (Central Nervous System)

Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011444203/buying
Reasons to buy

-Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
-Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
-Find and recognize significant and varied types of therapeutics under development for Autism (Central Nervous System).
-Classify potential new clients or partners in the target demographic.
-Develop tactical initiatives by understanding the focus areas of leading companies.
-Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
-Formulate corrective measures for pipeline projects by understanding Autism (Central Nervous System) pipeline depth and focus of Indication therapeutics.
-Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
-Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
For more information about this report http://www.reportsweb.com/autism-pipeline-review-h1-2018

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries

Pune:
505, 6th floor, Amanora Township,
Amanora Chambers, East Block,
Kharadi Road, Hadapsar, Pune-411028

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autism-Pipeline Review H1 2018 here

News-ID: 1165689 • Views: 132

More Releases from ReportsWeb

Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and
Aircraft Ignition System Market Growth Opportunity and Future Forecast by Leadin …
ReportsWeb.com has announced the addition of the “Global Aircraft Ignition System Market Insights Forecast to 2025” The report classifies the global Aircraft Ignition System Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. An ignition system generates a spark or heats an electrode to a high temperature to ignite a fuel-air mixture in spark ignition internal combustion engines oil-fired

All 5 Releases


More Releases for Autism

Autism-Pipeline Review H1 2018
Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review, H1 2018, provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child's sex, family history, fragile X syndrome, Tourette syndrome and epilepsy. Treatment includes SSRIs (selective serotonin reuptake inhibitors), antidepressants, antipsychotics, and sedatives. Report Highlights Publisher's Pharmaceutical
The U.S. Autism Treatment Market
Bharat Book Bureau Provides the Trending Market Research Report; on “The U.S. Autism Treatment Market”. The incidence of Autism among American children has soared from 1 in 150 in 2000 to 1 in 45 today, and 2.1 million children and adults now live with autism. Yet, few therapies exist to treat this disease - just a few medications and ABA (applied behavioral analysis) programs. This is a fragmented $1.8 billion market
Autism-Pipeline Review H2 2017
Summary:                                      ReportsWeb.com published “Autism-Pipeline Review H2 2017” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Autism-Pipeline Review H2 2017 provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism also known as complex developmental disability is a neurodevelopment disorder characterized by social interaction verbal
Autism Podcast released for Autism Sunday‏
AUTISM PODCAST RELEASED by Midnight in Chicago FOR AUTISM SUNDAY on February 8, 2009 Peterborough, ON: Thomas D. Taylor and Peterborough based MIDNIGHT IN CHICAGO have released their most recent free audio podcast on Autism entitled “Why Is There Autism: A Christian Perspective” to coincide with Autism Sunday on February 8. “As a Christian, it’s important for me to help others better understand what the Bible says about differences such as Autism,”
POWERED UP AGAINST AUTISM
Celebrities Come Out For the Cause BEVERLY HILLS, CA., NOVEMBER 17, 2007: Nearly one hundred celebrities powered up and showed their support over two days for the fight against autism by signing a special edition BugE Personal EV Transport. The vehicle, built especially by Harvey Coachworks of Knoxville, MD., will be offered for auction on EBay.com under “AMA Celebrity BugE” from Dec 10th to Dec 20th to benefit Autism Speaks,
Autism and Environmental Toxins
Cases of Autism Could Reach 4 Million in Next Decade Los Angeles, Calif., November 27, 2007 - There is now increasing evidence the world over that autism spectrum disorder (ASD) is currently on the rise. As of 2007, there are over 1.5 million diagnosed cases of ASD, a staggering 1 in every 150 persons, reported in the United States alone. If the rates of these disorders